Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.910 | 1.910 | 0.000 |
Stocks | 98.090 | 98.090 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.877 | 19.964 |
Price to Book | 2.666 | 3.692 |
Price to Sales | 2.644 | 2.453 |
Price to Cash Flow | 13.043 | 13.629 |
Dividend Yield | 1.972 | 1.593 |
5 Years Earnings Growth | 10.188 | 11.665 |
Name | Net % | Category Average |
---|---|---|
Technology | 22.860 | 28.042 |
Financial Services | 16.290 | 14.036 |
Industrials | 12.820 | 8.919 |
Healthcare | 11.490 | 13.512 |
Basic Materials | 11.410 | 3.009 |
Consumer Cyclical | 7.450 | 10.605 |
Consumer Defensive | 6.220 | 5.937 |
Energy | 4.290 | 4.205 |
Utilities | 4.000 | 2.446 |
Real Estate | 3.150 | 2.399 |
Number of long holdings: 46
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 4.60 | 424.01 | +1.91% | |
Parker-Hannifin | US7010941042 | 3.91 | 523.20 | +2.10% | |
Martin Marietta Materials | US5732841060 | 3.59 | 558.88 | +0.55% | |
Adobe | US00724F1012 | 3.36 | 455.80 | +1.66% | |
Lennar | US5260571048 | 3.28 | 159.37 | +1.05% | |
Ameriprise Financial | US03076C1062 | 3.01 | 427.65 | +0.73% | |
Corteva | US22052L1044 | 2.93 | 54.06 | +0.67% | |
ANSYS | US03662Q1058 | 2.73 | 327.07 | +3.14% | |
Merck&Co | US58933Y1055 | 2.62 | 129.45 | +0.57% | |
Microchip | US5950171042 | 2.60 | 94.30 | +0.32% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Aristotle US Equities I USD Capital | 421.69M | 3.75 | 6.84 | 10.51 | ||
Multi Manager Funds Fund of Mandata | 53.21M | 4.24 | -5.57 | 3.57 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review